EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting ferroptosis in gastric cancer: Strategies and opportunities

Jiahan Le, Guangzhao Pan, Che Zhang, Yitao Chen, Amit K Tiwari iD, Jiang-Jiang Qin

Immunological Reviews · 2024

DOI: 10.1111/imr.13280 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunological Reviews, 2024. Verfasst von Jiahan Le und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Ferroptosis. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 216 Literaturangaben. Gefördert von: Congressionally Directed Medical Research Programs, National Key R and D Program of China, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis is a novel form of programmed cell death morphologically, genetically, and biochemically distinct from other cell death pathways and characterized by the accumulation of iron‐dependent lipid peroxides and oxidative damage. It is now understood that ferroptosis plays an essential role in various biological processes, especially in the metabolism of iron, lipids, and amino acids. Gastric cancer (GC) is a prevalent malignant tumor worldwide with low early diagnosis rates and high metastasis rates, accounting for its relatively poor prognosis. Although chemotherapy is commonly used to treat GC, drug resistance often leads to poor therapeutic outcomes. In the last several years, extensive research on ferroptosis has highlighted its significant potential in GC therapy, providing a promising strategy to address drug resistance associated with standard cancer therapies. In this review, we offer an extensive summary of the key regulatory factors related to the mechanisms underlying ferroptosis. Various inducers and inhibitors specifically targeting ferroptosis are uncovered. Additionally, we explore the prospective applications and outcomes of these agents in the field of GC therapy, emphasizing their capacity to improve the outcomes of this patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsFerroptosisHumansAmino AcidsApoptosisIron

Stichwörter der Autor:innen

GPX4ferroptosisgastric cancerinducerinhibitormetabolismreactive oxygen species

Substanzen

Amino AcidsIron

Autor:innen und Institutionen

  • School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
  • Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
  • School of Molecular Medicine, Hangzhou Institute for Advanced Study, UCAS, Hangzhou, China.
  • Department of Pharmaceutical Sciences, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.

ORCID-Profile: Amit K Tiwari

Förderung

  • Congressionally Directed Medical Research Programs
  • National Key R and D Program of China
  • Natural Science Foundation of Zhejiang Province
  • Upper Gastrointestinal Cancer of Zhejiang Province

Zitieren

APA

Le, J., Pan, G., Zhang, C., Chen, Y., Tiwari, A. K., & Qin, J. J. (2024). Targeting ferroptosis in gastric cancer: Strategies and opportunities. Immunological Reviews. https://doi.org/10.1111/imr.13280

Vancouver

Le J, Pan G, Zhang C, Chen Y, Tiwari AK, Qin JJ. Targeting ferroptosis in gastric cancer: Strategies and opportunities. Immunological Reviews. 2024. doi:10.1111/imr.13280

BibTeX
@article{Le2024,
  author = {Le, Jiahan and Pan, Guangzhao and Zhang, Che and Chen, Yitao and Tiwari, Amit K and Qin, Jiang-Jiang},
  title = {Targeting ferroptosis in gastric cancer: Strategies and opportunities},
  journal = {Immunological Reviews},
  year = {2024},
  doi = {10.1111/imr.13280}
}
Kostenlos starten →